Direct-Acting Antivirals and Hepatitis C: The Ethics of Price and Rationing by Genotype
Clin Infect Dis
.
2018 Aug 31;67(6):983-984.
doi: 10.1093/cid/ciy239.
Authors
Alexis Walker
1
,
Angie Boyce
1
,
Gail Geller
1
,
Chloe L Thio
2
,
Jeffrey P Kahn
1
Affiliations
1
Berman Institute of Bioethics, Johns Hopkins University, Baltimore.
2
Department of Medicine, Johns Hopkins University, Baltimore.
PMID:
29617735
PMCID:
PMC7190899
DOI:
10.1093/cid/ciy239
No abstract available
Publication types
Letter
Comment
MeSH terms
Alleles
Antiviral Agents*
Female
Genotype
Hepacivirus / genetics
Hepatitis C*
Hepatitis C, Chronic*
Humans
Interleukins
Postpartum Period
Viral Load
Substances
Antiviral Agents
Interleukins
Grants and funding
RM1 HG009038/HG/NHGRI NIH HHS/United States